The Brown University Child and Adolescent Behavior Letter articles from November 2004

The Brown University Child and Adolescent Behavior Letter archives from November 2004

Pediatric antidepressant use debated; new warnings issued.(Special Eight-Page Report On Medication Use In Children)
November 1, 2004... The paucity of reliable research data was an important part of the discussion when the Food and Drug Administration's (FDA) Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committees (PDAC/PAC) met in Washington in...

Pharmacological interventions for adolescents with alcohol use disorders.(Using medications to treat substance abuse)
November 1, 2004... Currently, most treatments for adolescents with alcohol use disorders are limited to psychosocial interventions, despite the fact that not all adolescents benefit from these treatments. According to researchers from the University of Texas...

Lithium continuation may not be beneficial for mania.(What's New in Medication Research)
November 1, 2004... Although demonstrated as being an effective treatment for mania in adults, lithium has not been well-studied for the treatment of children and adolescents with acute mania. In what researchers claim is the first placebo-controlled study of...

Slight sleep disturbances induced by MPH.(What's New in Medication Research)(methylphenidate)
November 1, 2004... What is the relationship between attention-deficit/hyperactivity disorder (ADHD), stimulant response, and sleep disturbances in children? In a double-blind, placebo controlled, cross-over study, researchers determined that methylphenidate (MPH)...

Weight changes in autistic children taking risperidone.(What's New in Medication Research)
November 1, 2004... A study in the American Journal of Psychiatry reported that autistic children treated with risperidone for six months gained excessive weight, especially early during treatment. After treatment with the atypical antipsychotic, patients' weight...

FDA decision on SSRIs oversimplifies suicide risk.(Editor's Commentary)(United States. Food and Drug Administration)(selective serotonin reuptake inhibitors)
November 1, 2004... No child and adolescent mental health issue has ever captured the nation's attention like the current controversy around the use of selective serotonin reuptake inhibitors (SSRIs) in youngsters. Congressional bills, FDA hearings, front page...

Your child and medication.
November 1, 2004... One in ten of America's children has an emotional disturbance such as attention deficit hyperactivity disorder, depression or anxiety, that can cause unhappiness for the child and problems at home, at play, and at school. Many of these children...